AOPEP and familial hyperaldosteronism: For instance, individuals with FH typically suffer their first CVD event prior to the age of 50.175 Given that apo concentrations are mainly genetically defined (Figure 6) there may be a role for apo measurement in screening family members of young CVD patients as a first line strategy prior to genotyping.